Scorpius Holdings

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch SCPX and buy or sell other stocks, ETFs, and their options commission-free!

About SCPX

Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot, and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. 

CEO
Jeff A. Wolf, MBA
CEOJeff A. Wolf, MBA
Employees
84
Employees84
Headquarters
Morrisville, North Carolina
HeadquartersMorrisville, North Carolina
Founded
2008
Founded2008
Employees
84
Employees84

SCPX Key Statistics

Market cap
9.01K
Market cap9.01K
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
—
Dividend yield—
Average volume
13.08K
Average volume13.08K
High today
$0.05
High today$0.05
Low today
$0.0415
Low today$0.0415
Open price
$0.043
Open price$0.043
Volume
21.70K
Volume21.70K
52 Week high
$146.00
52 Week high$146.00
52 Week low
$0.0415
52 Week low$0.0415
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.